AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSL LIMITED

239.350

-2.540-1.05%

Volume:823.38K

Turnover:198.31M

Market Cap:115.90B

PE:27.12

High:241.050

Open:240.980

Low:237.100

Close:241.890

Loading ...

Overview Company News Filings

BRIEF-CSL Launches Andembry For Prevention Of Acute Attacks In Hereditary Angioedema In Japan

CSL Launches Andembry® for the Prevention of Acute Attacks in Hereditary Angioedema (Hae) in Japan

THOMSON REUTERS

How to build the perfect ASX share portfolio

What percentage of US CEOs expect a recession within 6 months?

3 of the best ASX 200 healthcare shares to bring your portfolio to life

CSL, Resmed Are Morgan Stanley's Australia Healthcare Picks in the Tariff Era -- Market Talk

Morgan Stanley’s top-ranked ASX healthcare picks for right now

Is the CSL share price a buy? Here's a top broker's view

Cautious Investors Not Rewarding Carlisle Companies Incorporated's (NYSE:CSL) Performance Completely

Simply Wall St.

How I'd invest in ASX 200 shares if I wanted to sleep well during market volatility

BUZZ-Australian healthcare stocks rise as Bell Potter sees most cos unfazed by potential tariffs

Are CSL Limited's (ASX:CSL) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Simply Wall St.

A bull market could be coming for ASX shares! Here's what I'm buying

The 3 ASX ETFs I'd buy to build a bulletproof portfolio

Australian shares end week in the red as tariff blitz dents sentiment

What I'd buy before the ASX rebounds: 3 high-conviction share picks

Which ASX shares are most impacted by the weak Australian dollar?

The Fallen: Stocks hitting 52-week lows (and what investors should do)

Stock Track | CSL Limited Soars 5.56% Despite Pharma Sector Slump, Defying Trump's Tariff Threats

Stock Track | CSL LIMITED Soars 5.56% as Pharmaceutical Tariff Exemption Boosts Investor Confidence

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CSL.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":239.35,"timestamp":1744870320000,"preClose":241.89,"halted":0,"volume":823376,"delay":0,"nameEN":"CSL LIMITED","floatShares":483950454,"shares":484212123,"eps":8.826767775171263,"marketStatus":"Not Yet Opened","change":-2.54,"latestTime":"04-17 16:12:00 AEST","open":240.98,"high":241.05,"low":237.1,"amount":198314478,"amplitude":0.01633,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":8.826767775171263,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":241.89,"dividendRate":0.017934,"openAndCloseTimeList":[[1744848000000,1744869600000]],"volumeRatio":0.7588854584128047,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":483950454,"roa":"6.69%","roe":"14.35%","lyrEps":8.524274,"volumeRatio":0.7588854584128047,"shares":484212123,"dividePrice":4.285625,"high":241.05,"amplitude":0.01633,"preClose":241.89,"low":237.1,"week52Low":228.61,"pbRate":"4.01","psRate":"4.88","week52High":308.856,"institutionHeld":0,"latestPrice":239.35,"eps":8.825048310684453,"divideRate":0.017934,"volume":823376,"delay":0,"ttmEps":8.825048310684453,"open":240.98,"prevYearClose":279.35,"prevWeekClose":239.35,"prevMonthClose":249.28,"prevQuarterClose":249.28,"fiveDayClose":241.78,"twentyDayClose":255.32,"sixtyDayClose":268.11},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528033279","title":"BRIEF-CSL Launches Andembry For Prevention Of Acute Attacks In Hereditary Angioedema In Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2528033279","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528033279?lang=en_us&edition=fundamental","pubTime":"2025-04-18 15:03","pubTimestamp":1744959812,"startTime":"0","endTime":"0","summary":"BRIEF-CSL Launches Andembry For Prevention Of Acute Attacks In Hereditary Angioedema In JapanApril 18 (Reuters) - CSL Ltd CSL.AX:CSL LAUNCHES ANDEMBRY® FOR THE PREVENTION OF ACUTE ATTACKS IN HEREDITARY ANGIOEDEMA (HAE) IN JAPANFurther company coverage: CSL.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250418:nFWN3QV3EV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7501","BK7067","CSL.AU","BK7511"],"gpt_icon":0},{"id":"2528803340","title":"CSL Launches Andembry® for the Prevention of Acute Attacks in Hereditary Angioedema (Hae) in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2528803340","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528803340?lang=en_us&edition=fundamental","pubTime":"2025-04-18 15:00","pubTimestamp":1744959653,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250418:nFWN3QV3EV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7508","BK7501","CSL.AU","BK7067"],"gpt_icon":0},{"id":"2528020777","title":"How to build the perfect ASX share portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2528020777","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528020777?lang=en_us&edition=fundamental","pubTime":"2025-04-18 07:08","pubTimestamp":1744931280,"startTime":"0","endTime":"0","summary":"Building a strong ASX share portfolio is one of the best ways to grow long-term wealth. But what does a perfect portfolio look like?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/18/how-to-build-the-perfect-asx-share-portfolio/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["WTC.AU","BK7153","MQG.AU","BK7501","IVV.AU","BK7155","BK7046","WES.AU","BK7067","BK7508","BK7099","BK7016","BK7041","BK7503","XRO.AU","BK7510","BK7511","PME.AU","BK7094","GMG.AU","NDQ.AU","CSL.AU"],"gpt_icon":1},{"id":"2527717403","title":"What percentage of US CEOs expect a recession within 6 months?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527717403","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527717403?lang=en_us&edition=fundamental","pubTime":"2025-04-16 06:44","pubTimestamp":1744757082,"startTime":"0","endTime":"0","summary":"According to a Chief Executive survey of more than 300 CEOs released on Monday, 62% said they forecasted a recession or other economic downturn in the next six months. The monthly survey reveals an index based on CEOs' rating of current business conditions and future outlook. According to the Chief Executive, it is now at its lowest level since November 2012. Tariff turmoil According to the survey, President Donald Trump's global tariff regime was a major factor in their negative outlook. Of the respondents, 67% said they do not approve of the tariffs, and 76% said they would negatively or very negatively impact their businesses this year. Mitchell Metal Products President and CEO Tim Zimmerman said :  Tariffs and the uncertainty of next steps that will be taken by President Trump will lead to very difficult economic times over the next year or two.  What does a recession look like?Whilst the survey focussed on the US economy, it is relevant for Australian investors because the S&P/ASX","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/16/what-percentage-of-us-ceos-expect-a-recession-within-6-months/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4550","OEX","USAW.SI","BK7501","XKO.AU","IVV","BK4559","TQQQ","BK7042","MNQmain","BK7067","BK7508","BK7511","CSL.AU","BK4534","SSO","NQmain","BK4585","USJW.SI","BK4504","QID","SDS",".IXIC","ESmain","XJO.AU","ARMR.AU","QLD","BK4588","TSYW.SI","PSQ","NVIW.SI","XAO.AU","OEF","SH","SQQQ","VOO","SPY","BK4581",".SPX","ARM.AU","TLS.AU"],"gpt_icon":1},{"id":"2527447668","title":"3 of the best ASX 200 healthcare shares to bring your portfolio to life","url":"https://stock-news.laohu8.com/highlight/detail?id=2527447668","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527447668?lang=en_us&edition=fundamental","pubTime":"2025-04-16 02:00","pubTimestamp":1744740000,"startTime":"0","endTime":"0","summary":"If your portfolio needs a health check, then the healthcare sector could be just what the doctor ordered. ASX 200 healthcare shares have a history of delivering strong, long-term returns thanks to con","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/16/3-of-the-best-asx-200-healthcare-shares-to-bring-your-portfolio-to-life/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU2471134523.USD","LU2471134952.CNY","LU2471134796.USD","LU1868836914.USD","BK7508","BK4552","IE0002270589.USD","BK7067","IE00BFXG1179.USD","IE0004091025.USD","RMD.AU","LU0048573561.USD","LU2237443622.USD","LU2750360997.AUD","LU2237443978.SGD","BK4127","BK4516","BK7501","PME.AU","BK7094","LU1791807156.HKD","LU1868836757.USD","LU2750360641.GBP","LU1868837136.USD","LU0742534661.SGD","BK7007","LU2471134879.HKD","BK4550","LU0061475181.USD","BK7511","LU2237443549.SGD","IE00B19Z3581.USD","LU2237443895.HKD","CSL.AU","IE00B19Z3B42.SGD","BK4585","LU1868836591.USD","LU1868837300.USD","BK4533","LU2237443465.HKD","IE0034235188.USD","LU2237438978.USD","BK4504","LU0251142724.SGD","BK4588","LU0106831901.USD","IE00BSNM7G36.USD","LU1668664300.SGD","IE0004086264.USD","LU2237443382.USD"],"gpt_icon":0},{"id":"2527481820","title":"CSL, Resmed Are Morgan Stanley's Australia Healthcare Picks in the Tariff Era -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2527481820","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527481820?lang=en_us&edition=fundamental","pubTime":"2025-04-15 11:51","pubTimestamp":1744689060,"startTime":"0","endTime":"0","summary":"0351 GMT - Biopharmaceutical company CSL and medical equipment firm Resmed have the best combination of attractive valuation and low tariff impact among Australian healthcare stocks, suggests Morgan Stanley equity analyst David L. Bailey. He estimates that CSL would need to raise prices by 1% and Resmed would need to raise prices by 2%-3% to offset the earnings impact from tariffs. But given their solid earnings per share growth, low earnings risk and valuation appeal, he says these companies are the \"most favorably positioned\" among peers. One word of caution--pharmaceuticals are currently excluded from reciprocal tariffs, but Trump has signaled he wants to put tariffs on that sector soon, which could impact CSL. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106831901.USD","LU0314104364.USD","LU0971096721.USD","LU1720051017.SGD","BK7508","LU2023251221.USD","LU1668664300.SGD","BK4548","RMD","LU1169590202.USD","BK4567","SGXZ23171101.USD","LU1989772840.SGD","LU0795875086.SGD","CSL","LU2347655156.SGD","LU1548497426.USD","LU1363072403.SGD","LU1732800096.USD","BK4137","BK4581","HCSG","LU0795875169.SGD","BK4534","BK4588","LU2271345857.HKD","CSL.AU","BK4127","BK7511","BK7501","LU0225283273.USD","LU2089284900.SGD","LU0158827781.USD","LU0320765646.SGD","BK4516","LU1074936037.SGD","LU0912757837.SGD","RMD.AU","LU1720051108.HKD","LU0170899867.USD","LU2089283258.USD","MS","LU1162221912.USD","LU2177674079.SGD","LU0158827948.USD","LU0728928796.USD","BK4086","BK4082","LU0098860793.USD","SG9999004303.SGD"],"gpt_icon":1},{"id":"2527107074","title":"Morgan Stanley’s top-ranked ASX healthcare picks for right now","url":"https://stock-news.laohu8.com/highlight/detail?id=2527107074","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527107074?lang=en_us&edition=fundamental","pubTime":"2025-04-15 10:46","pubTimestamp":1744685174,"startTime":"0","endTime":"0","summary":"Despite the latest noises out of the White House promising some tariff respite, Trump’s ongoing trade war remains the big spectre looming over markets.According to research from Morgan Stanley, one sector that could weather the storm is healthcare, especially if the worst were to happen and we entered a period of stagflation or even recession.Here are its two big-name stock picks and the reasons it thinks the sector is well-positioned right now.While pharmaceuticals are currently exempt from US tariffs, Trump hinted that an announcement on specific pharma tariffs could be expected “soon”.Regardless, Morgan Stanley believes leading ASX health stocks should be able to offset any tariff impact through minimal price increases.Using the GFC as an instructive case study, Morgan Stanley reviewed the performance of the healthcare industry against the ASX 200during that time in case we entered a similar period of lower growth, higher inflation and more unemployment.According to Morgan Stanley's","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/morgan-stanley-s-top-ranked-asx-healthcare-picks-for-right-now","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/morgan-stanley-s-top-ranked-asx-healthcare-picks-for-right-now","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["LU2347655156.SGD","LU2133065610.SGD","LU1363072403.SGD","LU1989772923.USD","LU0098860793.USD","BK7007","LU2357305700.SGD","MS","LU0006306889.USD","LU0106831901.USD","LU0225283273.USD","LU0795875086.SGD","BK4504","BK7508","LU2271345857.HKD","LU0912757837.SGD","BK7067","IE00BKVL7J92.USD","LU1720051108.HKD","LU0971096721.USD","LU0314104364.USD","BK4581","CSL.AU","RMD.AU","BK4516","BK7501","BK4585","LU0795875169.SGD","LU2028103732.USD","LU0158827948.USD","LU1720051017.SGD","LU1548497426.USD","IE00BZ1G4Q59.USD","LU1732800096.USD","LU2089284900.SGD","LU0106261372.USD","BK7511","LU0158827781.USD","LU1668664300.SGD","BK4588","LU2023251221.USD","LU2111349929.HKD","LU2089283258.USD","LU1989772840.SGD","LU1162221912.USD","LU0320765646.SGD","BK4127","LU1732799900.SGD","LU0267386448.USD","LU1074936037.SGD"],"gpt_icon":0},{"id":"2527109122","title":"Is the CSL share price a buy? Here's a top broker's view","url":"https://stock-news.laohu8.com/highlight/detail?id=2527109122","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527109122?lang=en_us&edition=fundamental","pubTime":"2025-04-15 06:47","pubTimestamp":1744670841,"startTime":"0","endTime":"0","summary":"The CSL Ltd (ASX: CSL) share price is down 15% since the start of 2025 and 20% in the last six months, as the chart below shows. After a sizeable decline, interested investors may be wondering whether","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/15/is-the-csl-share-price-a-buy-heres-a-top-brokers-view/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU1169589451.USD","CSL","BK7508","SG9999004303.SGD","BK7501","BK7067","LU1169590202.USD","BK4086","SGXZ23171101.USD","BK7511","LU0728928796.USD","CSL.AU"],"gpt_icon":0},{"id":"2527145867","title":"Cautious Investors Not Rewarding Carlisle Companies Incorporated's (NYSE:CSL) Performance Completely","url":"https://stock-news.laohu8.com/highlight/detail?id=2527145867","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527145867?lang=en_us&edition=fundamental","pubTime":"2025-04-14 23:19","pubTimestamp":1744643954,"startTime":"0","endTime":"0","summary":"There wouldn't be many who think Carlisle Companies Incorporated's ( NYSE:CSL ) price-to-earnings (or \"P/E\") ratio of...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/cautious-investors-not-rewarding-carlisle-companies-incorpor","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4086","BK4211","ISBC","NYSE","CSL","CSL.AU","SG9999004303.SGD","LU1169589451.USD","LU0728928796.USD","LU1169590202.USD","SGXZ23171101.USD"],"gpt_icon":0},{"id":"2527713444","title":"How I'd invest in ASX 200 shares if I wanted to sleep well during market volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=2527713444","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527713444?lang=en_us&edition=fundamental","pubTime":"2025-04-14 17:33","pubTimestamp":1744623232,"startTime":"0","endTime":"0","summary":"Let's face it — the share market can be a stressful place when prices are falling, headlines are screaming, and your portfolio is flashing red. But the truth is, volatility is part of the investment r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/14/how-id-invest-in-asx-200-shares-if-i-wanted-to-sleep-well-during-market-volatility/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7082","BK7099","IVV.AU","BK7067","BK4585","COL.AU","TLS.AU","BK4588","BK7510","BK7155","NDQ.AU","BK7501","BK7040","BK7007","QLTY.AU","RMD.AU","GMG.AU","BK7511","BK4550","BK7508","BK7042","CSL.AU","FDN"],"gpt_icon":0},{"id":"2527978495","title":"BUZZ-Australian healthcare stocks rise as Bell Potter sees most cos unfazed by potential tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2527978495","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527978495?lang=en_us&edition=fundamental","pubTime":"2025-04-14 13:17","pubTimestamp":1744607871,"startTime":"0","endTime":"0","summary":"BUZZ-Australian healthcare stocks rise as Bell Potter sees most cos unfazed by potential tariffs** Index of Australian Healthcare stocks .AXHJ rises 1.9%, tracking broadly positive market sentiment .A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nL4N3QS0C5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAN.AU","BK7048","BK7126","CSL.AU","PNV.AU","BK7511","BK7508","BK7501","TRJ.AU","NEU.AU","ARX.AU","BK7503","BK7067","BK7096"],"gpt_icon":0},{"id":"2527140929","title":"Are CSL Limited's (ASX:CSL) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527140929","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527140929?lang=en_us&edition=fundamental","pubTime":"2025-04-14 07:49","pubTimestamp":1744588166,"startTime":"0","endTime":"0","summary":"CSL  has had a rough three months with its share price down 17%. However, stock prices are usually driven by a company’s financials over the long term, which in this case look pretty respectable. Particularly, we will be paying attention to CSL's  ROE today.Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. Simply put, it is used to assess the profitability of a company in relation to its equity capital.The basis for attaching value to a company is, to a great extent, tied to its earnings growth. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. Doing so will help them establish if the stock's future looks promising or ominous. What is CSL worth today?The  intrinsic value infographic in our free research report  helps visualize whether CSL is currently mispriced by the market.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/csl-limiteds-asx-csl-fundamentals-234926416.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["SG9999004303.SGD","BK7511","BK7501","BK7508","BK7067","LU1169590202.USD","SGXZ23171101.USD","CSL.AU","CSL","LU0728928796.USD","BK4086","LU1169589451.USD"],"gpt_icon":0},{"id":"2527353279","title":"A bull market could be coming for ASX shares! Here's what I'm buying","url":"https://stock-news.laohu8.com/highlight/detail?id=2527353279","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527353279?lang=en_us&edition=fundamental","pubTime":"2025-04-13 04:11","pubTimestamp":1744488660,"startTime":"0","endTime":"0","summary":"I'll be looking to top up my positions in companies I already know and trust — names that have delivered for years and still have plenty of growth ahead. That includes:  CSL Ltd  – A global biotech leader with an enviable R&D pipeline and unmatched plasma network. Lovisa Holdings Ltd  – A fast-fashion jewellery success story with an expanding global footprint and excellent store-level economics. WiseTech Global Ltd  – A logistics tech giant with a long runway and dominant platform in the freight space. VanEck Morningstar Wide Moat ETF  – A curated portfolio of US companies with durable competitive advantages. Betashares Nasdaq 100 ETF  – Exposure to the world's biggest and most innovative tech names, now trading at more attractive prices.  Because whether we're already in the early stages of a new bull market — or just getting ready to turn the page — these are the kinds of investments I want leading the charge. Not just for the next few months, but for the long haul.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/13/a-bull-market-could-be-coming-for-asx-shares-heres-what-im-buying/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7508","WTC.AU","BK7128","BK7503","BK7016","BK7501","BK7067","NDQ.AU","LOV.AU","MOAT.AU","BK7511","CSL.AU"],"gpt_icon":0},{"id":"2527987958","title":"The 3 ASX ETFs I'd buy to build a bulletproof portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2527987958","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527987958?lang=en_us&edition=fundamental","pubTime":"2025-04-13 02:30","pubTimestamp":1744482600,"startTime":"0","endTime":"0","summary":"Building a long-term portfolio that can weather market storms, generate wealth, and keep things simple doesn't have to be complicated. In fact, sometimes the best results come from doing less — but do","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/13/the-3-asx-etfs-id-buy-to-build-a-bulletproof-portfolio/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["SDS","USJW.SI","OEX","NVDY","TSYW.SI","CSL.AU",".SPX","SPY","NVDD","XKO.AU","USAW.SI","VOO","ESmain","ARB.AU","NVDS","XJO.AU","IVV","SQQQ","AQLT.AU","IVV.AU","XAO.AU","DHHF.AU","FDN","QID","TQQQ","MNQmain","SNVD.UK","NVD2.UK","SH","NVDU","PNI.AU","NQmain","MACW.SI","PSQ",".IXIC","MQG.AU"],"gpt_icon":1},{"id":"2526817686","title":"Australian shares end week in the red as tariff blitz dents sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=2526817686","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526817686?lang=en_us&edition=fundamental","pubTime":"2025-04-11 14:38","pubTimestamp":1744353530,"startTime":"0","endTime":"0","summary":"Australian shares end week in the red as tariff blitz dents sentimentAXJO falls 0.3% in the weekHealth stocks post worst week since mid-February Energy stocks down 1.8%Updates to closeBy Rajasik Mukherjee. April 11  - Australian shares closed lower on Friday, ending a turbulent week dominated by U.S.-China trade tensions, as tit-for-tat tariffs fuelled global uncertainty and dented market sentiment.The S&P/ASX 200 index .AXJO ended 0.8% down at 7,646.5. The benchmark lost 0.3% for the week, its second consecutive weekly fall. Investors weathered a tumultuous week after U.S. tariffs took effect, only to be abruptly paused by President Donald Trump, with China notably excluded from the reprieve. The temporary reprieve sparked a sigh of relief on Thursday, but uncertainty surrounding trade policies soon crept in, eroding investor confidence.\"Trump's tariff pause relief rally stalled overnight as the reality set in that the imposts that remain in place still present a significant risk to g","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250411:nL3N3QP0F4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BHP.AU","BK7511","BK7142","BK7507","BK7135","BK7501","BK7508","CBA.AU","CSL.AU","WDS.AU","BK7095"],"gpt_icon":0},{"id":"2526547951","title":"What I'd buy before the ASX rebounds: 3 high-conviction share picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2526547951","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526547951?lang=en_us&edition=fundamental","pubTime":"2025-04-11 05:26","pubTimestamp":1744320372,"startTime":"0","endTime":"0","summary":"It is fair to say that the ASX has taken a major hit this month. But here's the thing: markets don't fall forever — and when the rebound comes, it tends to reward those who stayed calm and acted early","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/11/what-id-buy-before-the-asx-rebounds-3-high-conviction-share-picks/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU2237443465.HKD","BK4127","CSL.AU","LU2237443622.USD","IE0034235188.USD","LU2237443382.USD","IE00BSNM7G36.USD","LU2237443895.HKD","BK4504","IE00BFXG1179.USD","PME.AU","BK7155","IE00B19Z3B42.SGD","IE0002270589.USD","BK4588","IE00B19Z3581.USD","LU0251142724.SGD","LU2237438978.USD","BK4552","BK7099","BK4516","LU1868836591.USD","BK4585","BK7510","BK7094","LU1868837136.USD","LU1868836914.USD","BK4533","LU0096364046.USD","GMG.AU","LU0742534661.SGD","LU1791807156.HKD","LU2237443978.SGD","LU2471134523.USD","IE0004086264.USD","LU0048573561.USD","LU2237443549.SGD","IE0004091025.USD","LU1868836757.USD","LU2471134796.USD","BK7501","BK7511","LU2471134879.HKD","LU0106831901.USD","LU0251131958.USD","LU1868837300.USD","LU1668664300.SGD","BK7067","BK7508","LU0061475181.USD"],"gpt_icon":0},{"id":"2526932300","title":"Which ASX shares are most impacted by the weak Australian dollar?","url":"https://stock-news.laohu8.com/highlight/detail?id=2526932300","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526932300?lang=en_us&edition=fundamental","pubTime":"2025-04-10 14:20","pubTimestamp":1744266023,"startTime":"0","endTime":"0","summary":"Over the past week or so, all eyes have been fixed on the world's stock markets as the fallout from US President Donald Trump's new tariff regime rattled investors. However, there was another market t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/10/which-asx-shares-are-most-impacted-by-the-weak-australian-dollar/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7129","BK7095","MQG.AU","BK7511","RIO.AU","CSL.AU","BK7135","BK7508","XKO.AU","WDS.AU","WES.AU","JBH.AU","XAO.AU","HVN.AU","BK7041","BK7142","BK7104","NEM.AU","FMG.AU","BK7501","BK7507","BK7067","BK7046","BK7001","ANZ.AU","XJO.AU","BK7153","BHP.AU"],"gpt_icon":1},{"id":"2526364374","title":"The Fallen: Stocks hitting 52-week lows (and what investors should do)","url":"https://stock-news.laohu8.com/highlight/detail?id=2526364374","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526364374?lang=en_us&edition=fundamental","pubTime":"2025-04-10 10:48","pubTimestamp":1744253281,"startTime":"0","endTime":"0","summary":"Earlier this week, I covered The Outlaws – stocks hitting 52-week highs despite the market sinking.The Outlaw Stocks: The ASX names defying the sell-off and hitting 52-week highs. Unlike in 2022, when almost every asset class fell in lockstep, this year we’ve seen defensives and fixed income ETFs do what they’re meant to do: offer ballast in a storm.Now, let's flip the script and look at the stocks and ETFs which hit 52-week lows before today's bigger-than-Ben-Hur rally. We'll call them:The Fallen.To be sure, these aren’t necessarily all bad businesses. As fund managers like Emanuel Datt, Adam Dawes, and Nick Peros have pointed out, a stock hitting a 52-week low isn’t always a red flag.It's a potential opportunity to pick up quality at a discount.Due to the sheer number of names hitting 52-week low, we’ve  focused this wire on two key ASX sectors – resources and financials – with expert insights to help investors make sense of the wreckage.You can download the full list below or use th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/the-fallen-stocks-hitting-52-week-lows-and-what-investors-should-do","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/the-fallen-stocks-hitting-52-week-lows-and-what-investors-should-do","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["RMD","BK7507","LU2237443978.SGD","LU2471134879.HKD","LU2471134796.USD","LU2028103732.USD","NXL","BK7508","LU0795875169.SGD","LU2008162690.USD","LU2237443549.SGD","REA.AU","RIO.AU","LU2023251221.USD","LU2089284900.SGD","LU2471134523.USD","LU1548497426.USD","LU1732800096.USD","BK4516","BK4550","LU2089283258.USD","LU0795875086.SGD","RMD.AU","BK4127","BK4552","PNI.AU","BHP.AU","XRO.AU","BK7002","LU0225283273.USD","GQG.AU","LU1868837136.USD","LU0158827948.USD","MIN.AU","LU0170899867.USD","CSL.AU","NDQ.AU","NXL.AU","LU0314104364.USD","LU2237438978.USD","LU1162221912.USD","MFG.AU","IE00B19Z3B42.SGD","LU0912757837.SGD","BK4585","TNE.AU","LU0742534661.SGD","MQG.AU","LU0251131958.USD","BK7016"],"gpt_icon":0},{"id":"1128071192","title":"Stock Track | CSL Limited Soars 5.56% Despite Pharma Sector Slump, Defying Trump's Tariff Threats","url":"https://stock-news.laohu8.com/highlight/detail?id=1128071192","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128071192?lang=en_us&edition=fundamental","pubTime":"2025-04-10 08:04","pubTimestamp":1744243490,"startTime":"0","endTime":"0","summary":"CSL Limited  shares surged 5.56% in intraday trading on Thursday, bucking the trend of a broader pharmaceutical sector decline triggered by U.S. President Trump's renewed threats of tariffs on drug imports. The Australian biotechnology giant's impressive rally comes as a surprise, given the significant downturn experienced by many of its global peers.The pharmaceutical sector has been rocked by President Trump's recent comments about imposing tariffs on drug imports, causing widespread selloffs.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["CSL.AU"],"gpt_icon":0},{"id":"1123560789","title":"Stock Track | CSL LIMITED Soars 5.56% as Pharmaceutical Tariff Exemption Boosts Investor Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=1123560789","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123560789?lang=en_us&edition=fundamental","pubTime":"2025-04-10 08:04","pubTimestamp":1744243470,"startTime":"0","endTime":"0","summary":"CSL LIMITED  saw its stock price surge by 5.56% in Thursday's pre-market trading session, as investors reacted positively to news that the company remains unaffected by the latest round of U.S. tariffs on pharmaceutical products. This comes as a relief to shareholders following a period of uncertainty in the healthcare sector due to global trade tensions.The rally in CSL's stock price appears to be a direct response to a recent report by Macquarie Group, which highlighted that CSL has escaped th","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | CSL LIMITED Soars 5.56% as Pharmaceutical Tariff Exemption Boosts Investor Confidence","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["CSL.AU"],"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2025-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2025-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-09","payableDate":"2025-03-11","currency":"USD","dateTimestamp":1741525200000,"payDate":"2025-04-09"},{"date":"2025-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739228400000,"name":null,"time":"","dateTimestamp":1739192400000,"actualEps":null},{"date":"2024-09-09","symbol":"CSL.AU","amount":1.45,"announcedDate":"2024-08-13","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-10","defaultRemindTime":1725840000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-02","payableDate":"2024-09-10","currency":"USD","dateTimestamp":1725804000000,"payDate":"2024-10-02"},{"date":"2024-08-13","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723507200000,"name":null,"time":"","dateTimestamp":1723471200000,"actualEps":null},{"date":"2024-03-11","symbol":"CSL.AU","amount":1.19,"announcedDate":"2024-02-13","type":"dividend","market":"AU","newRecordDate":"2024-03-12","defaultRemindTime":1710111600000,"name":"CSL 公司","recordDate":"2024-04-03","payableDate":"2024-03-12","currency":"USD","dateTimestamp":1710075600000,"payDate":"2024-04-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}]}}